期刊文献+

老年性EBV阳性弥漫性大B细胞淋巴瘤临床病理特征 被引量:3

Clinicopathologic characteristics of EBV-positive diffuse large B-cell lymphoma in elderly
下载PDF
导出
摘要 目的探讨老年性EBV阳性弥漫性大B细胞淋巴瘤(EBV+DLBCL)临床病理特征。方法回顾2010-01—2014-07间所收集DLBCL病例的临床及病理资料,并辅以免疫组化及原位杂交分析。结果共收集154例DLBCL,125例具有完整的临床病理资料;组织学显示大部分为中心母细胞样;原位杂交显示13例DLBCL表达EBV(10.4%);Cox回归分析显示,EBV感染与患者年龄(≥60)、B症状(有)、结外累及的部位(≥2)、Ann Arbor分级(Ⅲ+Ⅳ)、IPI评分(2~5)显著相关(P〈0.05);且患者5年总体生存率与BEV的感染有显著关系(P=0.000)。结论 EBV的感染与DLBCL患者年龄、B症状、结外累及的部位、分级、IPI评分密切相关,EBV+DLBCL患者与EBV-DLBCL患者相比具有更差的预后。 Objective To investigate the clinicopathologic characteristics of EBV-positive diffuse large B-cell lymphoma of the elderly( EBV + DLBCL). Methods The clinical and pathological data of DLBCL cases were retrospectively analyzed from January 2010 to July 2014,combined with immunohistochemistry and in situ hybridization( ISH).Results A total of 154 DLBCL cases were collected,125 of which were analyzed with a complete set of clinical information; and hematoxylin-eosin examination showed most cases were characterized by a centroblastic population of neoplastic cells. ISH analysis showed that 13 cases expressed EBV( 10. 4%); Cox regress showed that EBER positivity was significantly associated with age( ≥60 years),the presence of B symptom,more than one extranodal involvement,more advanced stage,higher international prognostic index( IPI)( P = 0. 003,0. 024,0. 008,0. 001,0. 027,respectively);there were significant difference in 5-year overall survival rate between the EBER + and EBER- groups( P = 0. 000).Conclusion EBER positivity is significantly associated with age,B symptom,the sites of extranodal involvement,stage and IPI in DLBCL patients. EBER positive patients with DLBCL demonstrate substantially poorer 5-year overall survival rate than EBER negative ones.
出处 《诊断病理学杂志》 CSCD 2015年第11期661-664,668,共5页 Chinese Journal of Diagnostic Pathology
基金 广州市医药卫生科技项目(20141A011013)
关键词 老年性 弥漫性大B细胞淋巴瘤 EBV 临床病理特征 Elderly Diffuse large B-cell lymphoma EBV Clinicopathologic feature
  • 相关文献

参考文献7

二级参考文献40

  • 1刘艳辉,庄恒国,林汉良,吴秋良,罗东兰,李丽,骆新兰.结节性淋巴细胞为主型霍奇金淋巴瘤和富于T细胞和(或)组织细胞的B细胞淋巴瘤的鉴别诊断[J].中华肿瘤杂志,2006,28(8):594-598. 被引量:4
  • 2曲飞,刘惠萍,张秀兰.子宫体原发性弥漫性大B细胞淋巴瘤临床病理观察[J].诊断病理学杂志,2007,14(3):199-201. 被引量:12
  • 3Dupuis J,Emile JF,Mounier N,et al.Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma,unspecified.A Groupe d' Etude des Lymphomes de 1' Adulte (GELA) study.Blood,2006,108(13):4163-4169.
  • 4Zettl A,Lee SS,RudigerT,et al.Epstein-Barr virus-Associated B-Cell lymphoproliferative disorders in angloimmunoblastic T-Cell lymphoma and peripheral T-Cell lymphoma,Unspecified.Am J Clin Pathol,2002,117(3):368-379.
  • 5Furlan A,Pietrogrande F,Marino F,et al.Sequential development of large B cell lymphoma in a patient with peripheral T-cell lymphoma.Haematologica,2008,93(1):e6-e8.
  • 6Tucci A,Motta M,Ungari M,et al.The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis.Haemalologica,2005,90 (3):348-352.
  • 7Weisel KC,Weidmann E,Anagnostopoulos I,et al.Epstein-Barr vims-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.bit J Hematol,2008,88 (4).434-440.
  • 8Rai KR,Freter CE,Mercier RJ,et al.Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.J Clin Oncol,2002,20 (18):3891-3897.
  • 9Chobrial IM,Otteman LA,White WL.An EBV-positive lymphoproliferative disorder after therapy with alemtuzumab.N Engl J Med,2003,349(26):2570-2572.
  • 10Fisher R,Miller T,O'Connor O.Diffuse aggressive lymphoma//Broudy V,Berliner N,Larson R,et al.Hematology 2004.American Society of Hematology Education Program Book.Amsterdam:Elsevier Health Sciences,2004:221-236.

共引文献30

同被引文献26

  • 1Nakamura S, Jaffe ES. Swerdlow SH, et al. EBV positive dif fuse large B-cell lymphoma of the elderly//[M]. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France= Interna tional Agency for Research on Cancer,2008=243 244.
  • 2Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J]. Blood, 2004,103 (1) : 275-282.
  • 3Cohen M, Narbaitz M, Metrebian F, et al. Epstein-Barr viruspositive diffuse large I3 cell lymphoma association is not only re stricted to elderly patients[J]. Int J Cancer, 2014, 135 (12) .2816-2824.
  • 4Hong JY, Yoon DH, Suh C, et al. EBV-positive diffuse large B cell lymphoma in young adults: is this a distinct disease entity? [J]. Ann Oncol,2015;26(3):548-555.
  • 5Sato A, Nakamura N, Kojima M, et al. The clinical outcome of Epstein-Barrvirus positive diffuse large B cell lymphoma of the elderly in the rituximab era[J]. Cancer Sci, 2014,105(9):11701175.
  • 6Ok CY, Li L, Xu-Monette ZY, et al. Prevalence and clinical implications of Epstein-Barr virus infection in de novo diffuse large Bcell lymphoma in Western countries[J2. Clin Cancer Res, 2014,20(18) :2338-2349.
  • 7Song CG, Huang JJ, Li YJ, et al. Epstein-Barr virus-positive diffuse large B-cell lymphoma in the elderly: A matched casecontrol analysis[J/CD]. PLoS One, 2015,10(7) = e0133973.
  • 8Pan Y, Meng B, Zhang H, et al. Low incidence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in Tianjin, northern China[J]. Leuk Lymphoma,2013,54(2) :298303.
  • 9Behran Bid, Castillo JJ, Morales D, et al. EBV positive diffuse large B cell lymphoma of the elderly: a case series from Peru[J].Am J Hematol 2011,86(8) :663-667.
  • 10Park S, Lee J, Ko YH, et al. The impact of Epstein Barr virus status on clinical outcome in diffuse large B-cell lymphoma[J].Blood 2007,110(3) :972 978.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部